Skip to Content

Imagenetix Inc IAGX

Morningstar Rating
$0.00 0.00 (100.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IAGX is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$8.90
Uncertainty
Extreme
1-Star Price
$1.55
5-Star Price
$4.52
Economic Moat
Ssfzc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IAGX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$5,684.59
Volume/Avg
48,186 / 87,426

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Imagenetix Inc is engaged in developing, formulating licensing and selling over-the-counter, natural-based nutritional supplements. Its products include Celadrin, a product formulation for joint health; and Periodyne a periodontal product. These products are offered through multiple channels of distribution, including direct marketing companies, also known as network marketing or multi-level marketing companies and chain store retailers. Geographically all the business activities are functioned primarily through the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
5
Website

Valuation

Metric
IAGX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
IAGX
Quick Ratio
0.48
Current Ratio
0.69
Interest Coverage
−6.25
Quick Ratio
IAGX

Profitability

Metric
IAGX
Return on Assets (Normalized)
−94.92%
Return on Equity (Normalized)
−541.72%
Return on Invested Capital (Normalized)
−219.94%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AGplmt$87.4 Bil
MKKGY
Merck KGaA ADRNcypht$74.3 Bil
HLN
Haleon PLC ADRGpjyz$38.5 Bil
VTRS
Viatris IncGwyd$15.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRYsg$12.4 Bil
CTLT
Catalent IncZqvdby$10.3 Bil
CURLF
Curaleaf Holdings IncVgvb$3.6 Bil
PRGO
Perrigo Co PLCYsy$3.6 Bil
PBH
Prestige Consumer Healthcare IncXkbscld$3.5 Bil
GTBIF
Green Thumb Industries IncVndv$3.1 Bil

Sponsor Center